Article Details

Lonza Acquires Roche's US Commercial Biologics Manufacturing Site for $1.2 Billion

Retrieved on: 2024-03-25 15:49:59

Tags for this article:

Click the tags to see associated articles and topics

Lonza Acquires Roche's US Commercial Biologics Manufacturing Site for $1.2 Billion. View article details on hiswai:

Excerpt

Lonza announced on March 20, 2024 that is has signed an agreement to acquire from Roche its Vacaville, Calif., site, a large-scale biologics ...

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up